Inventor · disambiguated record
Eric C. Breinlinger
Also filed as: BREINLINGER ERIC · BREINLINGER ERIC C
12 granted patents·13 pending applications·103 citations·filing 2007–2021
87Inventor score
Top patents by PatentIndex Score
25 records- 0195US8785639B2Substituted dihydropyrazolo[3,4-D]pyrrolo[2,3-B]pyridines and methods of use thereofWISHART NEIL·Filed 2010·Granted Jul 22, 2014·57 cites·9 claims
- 0290US7834039B2Oxadiazole compoundsABBOTT LAB·Filed 2007·Granted Nov 16, 2010·36 cites·13 claims
- 0383US10508113B2Inhibitors of tyrosine kinase 2 mediated signalingABBVIE INC·Filed 2019·Granted Dec 17, 2019·3 cites·30 claims
- 0478US9856253B2Tricyclic modulators of TNF signalingABBVIE INC·Filed 2016·Granted Jan 2, 2018·2 cites·19 claims
- 0575US9879016B2Indazolones as modulators of TNF signalingABBVIE INC·Filed 2016·Granted Jan 30, 2018·2 cites·26 claims
- 0669US10106501B2Nuclear receptor modulatorsABBVIE INC·Filed 2016·Granted Oct 23, 2018·1 cites·53 claims
- 0769US2023066771A1Nuclear receptor modulatorsABBVIE INC·Filed 2021·Application pending·0 cites
- 0865US8217027B2Sphingosine-1-phosphate receptor agonist and antagonist compoundsWALLACE GRIER A·Filed 2008·Granted Jul 10, 2012·2 cites·18 claims
- 0965US2021130293A1Nuclear receptor modulatorsABBVIE INC·Filed 2019·Application pending·0 cites
- 1057US2020255423A1Inhibitors of tyrosine kinase 2 mediated signalingABBVIE INC·Filed 2019·Application pending·0 cites
- 1156US2019055196A1Nuclear receptor modulatorsABBVIE INC·Filed 2018·Application pending·0 cites
- 1254US10266532B2Tricyclic modulators of TNF signalingABBVIE INC·Filed 2017·Granted Apr 23, 2019·0 cites·18 claims
- 1351US2014349970A1Novel tricyclic compoundsWISHART NEIL·Filed 2014·Application pending·0 cites
- 1450US10160748B2Indazolones as modulators of tnf signalingABBVIE INC·Filed 2017·Granted Dec 25, 2018·0 cites·20 claims
- 1550US2009069288A1Novel therapeutic compoundsBREINLINGER ERIC C·Filed 2008·Application pending·0 cites
- 1649US10273238B2Indazolones as modulators of TNF signalingABBVIE INC·Filed 2017·Granted Apr 30, 2019·0 cites·22 claims
- 1748US2008249305A1Novel imidazole based heterocyclesCALDERWOOD DAVID J·Filed 2008·Application pending·0 cites
- 1846US2008242862A1Novel imidazo based heterocyclesCALDERWOOD DAVID J·Filed 2007·Application pending·0 cites
- 1944US2014315883A16H-IMIDAZO[1,5-a]PYRROLO[2,3-e]PYRAZINE COMPOUNDSBREINLINGER ERIC·Filed 2014·Application pending·0 cites
- 2042US9029409B2Isoxazolines as therapeutic agentsCALDERWOOD DAVID J·Filed 2012·Granted May 12, 2015·0 cites·17 claims
- 2142US2016304496A1Indazolones as modulators of tnf signalingABBVIE INC·Filed 2016·Application pending·0 cites
- 2241US9115151B2Substituted 2,10-dihydro-9-oxa-1,2,4A-triazaphenanthren-3-ones and uses thereofGEORGE DAWN M·Filed 2014·Granted Aug 25, 2015·0 cites·19 claims
- 2337US2015297596A1Isoxazolines as therapeutic agentsABBVIE INC·Filed 2015·Application pending·0 cites
- 2434US2012238549A1Nuclear Hormone Receptor ModulatorsCUSACK KEVIN P·Filed 2012·Application pending·0 cites
- 2533US2011207704A1Novel Oxadiazole CompoundsABBOTT LAB·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Eric C. Breinlinger files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →